14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today ANIK ranks #17122 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Anika Therapeutics Inc. Stock Forecast NASDAQ:ANIK

$31.55 (-2.14%)

Volume: 45k

Closed: Jan 26, 2022

Hollow Logo Score: -4.450

Anika Therapeutics Inc. Stock Forecast

$31.55 (-2.14%)

Volume: 45k

Closed: Jan 26, 2022

Score Hollow Logo -4.450

Anika Therapeutics Inc. Company Profile

32 Wiggins Avenue

Bedford MA 01730

781-457-9000

www.anikatherapeutics.com

Industry: Medical Devices

Sector: Healthcare

Anika Therapeutics Inc.

Description

Anika Therapeutics, Inc., together with its subsidiaries, provides therapeutic pain management solutions for patients with degenerative orthopedic diseases and traumatic conditions in the United States, Canada, Europe, and internationally. The company develops, manufactures, and commercializes therapeutic products based on its proprietary hyaluronic acid (HA) technology. Its orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; Hyalofast, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery; Hyalonect, a woven gauze used as a graft wrap; Hyaloss used to mix blood/bone grafts to form a paste for bone regeneration; and Hyaloglide, an ACP gel used in tenolysis treatment. The company’s dermal products include wound care products that comprise Hyalomatrix and Hyalofill for treatment of complex wounds, such as burns and ulcers, and for use in connection with the regeneration of skin; and ELEVESS, an aesthetic dermatology product. Its surgical products comprise Hyalobarrier, a post-operative adhesion barrier for use in the abdomino-pelvic area; INCERT, a HA product for the prevention of spinal post-surgical adhesions; Merogel, a woven fleece nasal packing; and Merogel Injectable, a viscous hydrogel. The company’s ophthalmic products include STAARVISC-II, Optivisc, AnikaVisc, and NUVISC that are injectable HA products used as viscoelastic agents in ophthalmic surgical procedures, including cataract extraction and intraocular lens implantation. Its veterinary product comprise HYVISC, an injectable HA product used for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE